Palvella Therapeutics, Inc. (PVLA)

CIK 1583648 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Palvella Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 5, 202610-Q0001193125-26-448638
Nov 5, 20268-K0001193125-26-448594
Oct 28, 20268-K0001193125-26-435113
Oct 28, 2026SCHEDULE 13G/A0000053417-26-000064
Oct 23, 202640001104659-26-118466
Oct 21, 20261440001967940-26-000055
Oct 14, 202640001104659-26-115916
Oct 13, 20261440001967940-26-000053
Sep 18, 202640001104659-26-108930
Sep 16, 20261440001967940-26-000051
Sep 15, 202640001104659-26-108022
Sep 11, 20261440001967940-26-000050
Sep 4, 202640001104659-26-105494
Sep 2, 20261440001950047-26-008991
Aug 20, 202640001104659-26-099222
Aug 19, 20261440001967940-26-000044
Aug 14, 2026SCHEDULE 13G/A0001999371-26-018011
Aug 14, 2026SCHEDULE 13G/A0000921895-26-002180
Aug 10, 2026SCHEDULE 13G0001137774-26-000180
Aug 4, 202610-Q0001193125-26-331574
Aug 4, 2026S-80001104659-26-090394
Aug 4, 20268-K0001193125-26-331556
Aug 3, 2026SCHEDULE 13G0000053417-26-000050
Jul 29, 2026SCHEDULE 13G0002012383-26-002924
Jul 17, 202640001104659-26-084620